2011-01-25 00:00:00,Gilead Announces Share Repurchase Program
2011-02-07 00:00:00,Gilead Announces Notification of ANDA Filing for Tamiflu
2011-03-04 00:00:00,FDA Removes Warning About Potential Liver Injury From Boxed Warning Of Prescribing Information For Gilead Letairis
2011-03-23 00:00:00,Gilead To Offer Senior Notes
2011-03-30 00:00:00,Gilead And Yale School of Medicine Announce Cancer Research Collaboration
2011-04-04 00:00:00,Hospitalization Not Cut By Gilead Heart
2011-06-28 00:00:00,Gilead Announces Agreement With Tibotec Pharmaceuticals To Develop And Commercialize New Combination Of Cobicistat And Prezista
2011-07-12 00:00:00,Ranbaxy Laboratories Limited Announces Licensing Agreement With Gilead Inc
2011-09-20 00:00:00,JAPAN TOBACCO Announces Result of Phase 3 Clinical Trial of by Gilead Inc
2011-10-24 00:00:00,Gilead And GlobeImmune Announce License And Collaboration Agreement to Develop Therapeutic Vaccine Products For Treatment of Chronic Hepatitis B Infection
2011-10-26 00:00:00,Squibb And Gilead Announces Licensing Agreement For Development And Commercialization Of New Combination Pill
2011-10-27 00:00:00,Gilead Raises Lower End Of Prior FY 2011 Product Sales Call
2011-10-28 00:00:00,JAPAN TOBACCO Announces Filing of NDA for
2011-12-05 00:00:00,Gilead Boosting Meets Primary Objective in Pivotal Phase 3 Study
2011-12-06 00:00:00,Gilead Prices Billion Of Senior Unsecured Notes
2012-01-12 00:00:00,Gilead Completes Tender Offer for All Outstanding Shares Of
2012-01-17 00:00:00,Gilead Completes Acquisition Of
2012-02-02 00:00:00,Gilead Issues FY 2012 Product Sales Call
2012-02-14 00:00:00,Gilead Announces FDA Grants Priority Review For Truvada For Reducing The Risk Of Acquiring HIV Infection
2012-04-19 00:00:00,Gilead Announces Sustained Virologic Response Data For Regimen Of Plus Pegylated Interferon And Ribavirin In Genotype One Hepatitis C Patients
2012-05-01 00:00:00,Gilead Initiates Phase 3 Clinical Trial Evaluating For Treatment Of Chronic Lymphocytic Leukemia
2012-05-10 00:00:00,Gilead Reaffirms FY 2012 Net Sales Call
2012-06-27 00:00:00,Gilead Submits New Drug Application To FDA For HIV Integrase Inhibitor Elvitegravir For Treatment Experienced Patients
2012-07-16 00:00:00,Food and Drug Administration Approves Gilead Truvada for Reducing Risk of Acquiring HIV
2012-07-19 00:00:00,Electronics For Announces Sale Agreement With Gilead Sciences
2012-07-27 00:00:00,Gilead Reaffirms FY 2012 Net Product Sales Call
2012-08-02 00:00:00,Gilead Announces New Collaboration With Mylan Laboratories Ltd And Other Indian Partners
2012-08-27 00:00:00,FDA Approves Gilead Sciences Stribild
2012-09-12 00:00:00,Gilead Sciences Inc Reaffirms FY 2012 Revenue Call
2012-10-09 00:00:00,Analyst Favorites With Strong Buyback Gilead Sciences Ranks As a Top
2012-10-11 00:00:00,Gilead Sciences Investment Recent Ratings Updates
2012-10-16 00:00:00,The Zacks Analyst Blog Arena Gilead Sciences
2012-10-17 00:00:00,RBC Capital Reaffirms Outperform Rating on Gilead Sciences
2012-10-18 00:00:00,Gilead Sciences Investment Weekly Ratings Changes
2012-10-24 00:00:00,Healthcare Gilead XOMA NuVasive
